CTAB
Description
What is CTAB?
CTAB or Cetrimonium bromide can be used for several purposes in the pharma industry. As a pharmaceutical ingredient, it is an antiseptic agent with various antibacterial, antifungal and other antimicrobial properties. It is used in various products such as throat lozenges and antiseptic topical gels and creams for a range of purposes. As a processing aid or auxiliary, it can be used in the downstream vaccine manufacturing process, typically for both bacterial polysaccharide vaccines and viral vaccines (e.g. influenza).
Uniform quality
Our FeF® CTAB USP/NF product has proven efficacy against a broad spectrum of microorganisms (gram + and – & acid fast bacteria, yeast, moulds). They are effective through a wide pH range, are surface active/adhesive cationic agents and do not add unpleasant odour/colour to finished formulations.
The uniform quality of our products – and of our customers’ products – is ensured by our efficient quality management systems, dedicated equipment, well established processes and rigorous laboratory quality control.
Contact
Phil StaffordInternational Sales Manager for US and Europe
Phone: +45 2429 4174
Pharmaceutical Grade
FeF® CTAB USP/NF
CAS No. 57-09-0.
Consists of Hexadecyl trimethyl ammonium bromide. Contains approx. 99% active ingredients.
Please note that product Item no. 7800023 is only manufactured to order.
| Packing sizes | Item no. | Product image |
|---|---|---|
| 25 kg (Double plastic bags in cardboard box) | 7800022 |  |
| 25 kg (Double plastic bags in plastic drums) | 7800023 |  |
Documentation and services
European Drug Master File (ASMF)
GMP Certificate (enter Certificate number DK API-H 00073316 and choose Denmark in the country field list)
Certificate of Analysis (current version of pharmacopoeia)
Datasheet
Customer audits
Stability results
Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, animal testing, etc.)
Reach
Change Notification Statement
Pre-filled Supplier Questionnaire
Impurity profile
Description of the manufacturing process
Process flowchart
Packaging details
Quality Agreements
Exposure ScenarioDownload pdf
Contact us
Corporate Headquaters
Novo Nordisk Pharmatech A/S
Københavnsvej 216 DK - 4600 Køge
Denmark
Phone: +45 5667 1000
Fax: +45 5667 1001
For complaints or comments about our company or our products, please contact
